China FDA Solicits Comments on Conditional Approvals for New Drugs and Compassionate Use of Investigational Drugs

Published date27 December 2017
Law FirmRopes & Gray LLP
Subject MatterMedical Devices,China,Policy Drafting,Comment Period,China FDA,Pharmaceutical Industry,Marketing Authorization Application

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT